Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
8-KReport of unscheduled material events or corporate eventFeb 23, 2017View HTMLDownload DOCDownload PDFDownload XLS
5Annual filing director officer or owner of more than ten percent.Feb 14, 2017View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2017View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2017View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2017View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 10, 2017View HTMLDownload DOCDownload PDFDownload XLS
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsFeb 2, 2017View HTMLDownload DOCDownload PDF
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsJan 30, 2017View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJan 27, 2017View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GJan 19, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 12, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 10, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 10, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 3, 2017View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventDec 19, 2016View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventDec 9, 2016View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventDec 2, 2016View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 29, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 23, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 22, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 18, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 14, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 14, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 9, 2016View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionNov 3, 2016View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
1-25      26-50      51-75      76-100      101-125      126-136

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI) PKU, LEMS

Products

Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information